Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism.

AUTOR(ES)

Minden, M D

RESUMO

Bone marrow transplantation has become an accepted modality in the treatment of acute leukemia. With this therapy, it is possible to obtain long-term disease-free survival. However, leukemia recurs occasionally. In most cases, leukemic relapse is of recipient origin. There have been several reports, though, of leukemia developing in donor cells. These cases have been limited to instances in which there is an easily identifiable chromosome difference or abnormality, usually a sex chromosome. In this paper we describe the use of restriction fragment-length polymorphism analysis to determine the origin of recurrent leukemia cells in which no identifying chromosome was present. We found that the leukemia had recurred in recipient cells. We also were able to demonstrate the presence of normal hemopoietic cells of donor origin.

Documentos Relacionados

• Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
• Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism.
• Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism.
• Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism.
• Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism.